Decompressive Craniectomy for Supratentorial ICH
Decompressive craniectomy with or without hematoma evacuation should be performed in this patient to reduce mortality, as they meet all critical criteria: supratentorial ICH >30 mL, ≥5 mm midline shift, GCS ≤8, age <70 years, and refractory to medical management. 1, 2
Primary Indication Framework
Your patient meets the established threshold criteria for surgical intervention:
- Hematoma volume >30 mL is a powerful predictor of mortality and constitutes indication for decompressive intervention 2, 3
- Midline shift ≥5 mm is the established threshold for considering surgical evacuation, particularly when combined with neurological deterioration 4, 2
- GCS ≤8 (comatose state) represents severe neurological compromise warranting decompressive surgery 1, 2
- Age <70 years with good premorbid status places the patient in the optimal surgical candidate category 2, 5
Mortality Benefit vs Functional Outcome
The evidence strongly supports a mortality reduction with decompressive craniectomy in this clinical scenario:
- Meta-analyses demonstrate 26% mortality with decompressive craniectomy versus 53% with medical management alone in matched cohorts 2, 6
- The American Heart Association/American Stroke Association provides a Class 2b recommendation (Level C-LD) for mortality reduction 1, 2
However, functional outcomes remain uncertain. The AHA/ASA explicitly states that while mortality may be reduced, evidence for functional benefit is lacking 1, 2. This critical distinction must be discussed with the family—surgery is life-saving but does not guarantee good functional recovery.
Surgical Approach: With or Without Hematoma Evacuation
The decision between decompressive craniectomy alone versus combined with hematoma evacuation depends on specific patient factors:
Decompressive Craniectomy WITH Hematoma Evacuation:
- Preferred when: Patient is younger (age 30-70 years), has subcortical hematoma location, minimal intraventricular extension, and preoperative GCS 6-12 5
- One RCT showed 70% favorable outcomes (mRS 0-4) with DC plus expansive duraplasty and hematoma evacuation versus 20% with evacuation alone 2, 5
- Particularly beneficial in right hemispheric hemorrhages in younger patients 3
Decompressive Craniectomy WITHOUT Hematoma Evacuation:
- Equally effective for mortality reduction when the primary goal is ICP control 1, 6
- Feasibility demonstrated with 75% survival and 75% good outcomes (mRS 0-4) in selected cohorts 6
- May be preferred when hematoma is deep (basal ganglia) and evacuation carries higher surgical risk 2
No clear superiority has been demonstrated between DC with versus without clot evacuation for mortality reduction. 1
Timing of Intervention
Surgical intervention should occur within 8 hours of hemorrhage onset to optimize outcomes 2, 4:
- Meta-analyses suggest improved outcomes with surgery within 8 hours 4
- Critical pitfall: Ultra-early surgery within 4 hours increases rebleeding risk and should be avoided 2, 4
- Optimal window appears to be 4-8 hours after symptom onset 2, 4
Technical Surgical Considerations
The craniectomy must be adequate to achieve decompressive effect:
- Minimum craniectomy size: 150 mm diameter 6
- Dural opening is mandatory to achieve effective decompression 1, 6
- Expansive duraplasty should be performed when combined with hematoma evacuation 5
Post-Operative Management
Following decompressive craniectomy, critical care priorities include:
- ICP monitoring is essential in patients with severe deficits or large hematomas 7
- Maintain cerebral perfusion pressure 60-70 mmHg 7
- Monitor for complications: pneumocephalus, rebleeding (especially if surgery <4 hours), hydrocephalus (15-20% incidence), and infection 2, 5
- Normothermia (36-37°C) and glucose control (6-10 mmol/L) should be maintained 7
Critical Pitfalls to Avoid
Do not use baseline severity scores as the sole basis for limiting life-sustaining treatment 2—while GCS and ICH scores predict mortality, they should frame communication, not dictate withdrawal decisions
Do not place external ventricular drain alone when significant mass effect is present; it must be combined with surgical decompression 7
Do not delay surgery beyond 8 hours unless compelling contraindications exist 7, 4
Do not operate within 4 hours due to increased rebleeding risk 2, 4
Ensure adequate craniectomy size (≥150 mm)—inadequate decompression negates the benefit 6
Prognostic Factors That Favor Better Outcomes
Even within surgical candidates, certain factors predict superior functional recovery:
- Higher admission GCS (6-12 versus 4-5) 5
- Younger age (30-70 years, particularly <50 years) 5, 3
- Smaller hematoma volume (though >30 mL still warrants surgery) 5
- Subcortical location versus deep basal ganglia 5
- Absent or minimal midline shift preoperatively 5
- Absent intraventricular extension 5, 8
- Normal oculocephalic reflex preoperatively 3
Your patient's age <70 years and good premorbid status are favorable prognostic indicators within the surgical cohort 2, 5.